Drug Pipeline

CDX-301 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03804944 Converting HR+ Breast Cancer Into an Individualized Vaccine Breast Cancer Recruiting
Phase 1
NCT05010200 The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the… Prostate Cancer Active, Not Recruiting
NCT04930783 NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma Melanoma Active, Not Recruiting
Sponsors Running CDX-301 Trials
Weill Medical College of Cornell University (1) Dana-Farber Cancer Institute (1) Ashutosh Kumar Tewari (1)
Disease Areas
Breast Cancer (1) Melanoma (1) Prostate Cancer (1)
Get alerts when CDX-301 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free